Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Polycythemia Vera 11Brain Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia 9Glioblastoma 9Leukemia, Myeloid, Acute 8Meningioma 7Head and Neck Neoplasms 7Gliosarcoma 6Myelodysplastic Syndromes 4Glioma 4Central Nervous System Neoplasms 4Neoplasms 3Myeloproliferative Disorders 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Laryngeal Neoplasms 3Esophageal Neoplasms 3Treatment-Refractory Solid Tumors 2Thrombocythemia, Essential 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Primary Myelofibrosis 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Oropharyngeal Neoplasms 2Myelodysplastic-Myeloproliferative Diseases 2Hypopharyngeal Neoplasms 2

Interventions

Cisplatin 41Gemcitabine 25Radiotherapy, Intensity-Modulated 15Fluorouracil 15Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5toripalimab 4spartalizumab 4Surveys and Questionnaires 4Bevacizumab 4camrelizumab 3Nivolumab 3Induction Chemotherapy 3Immunohistochemistry 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Hydroxyurea × Clear all
NCT00002951 2013-09-05

Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

University of Chicago

Phase 2 Completed
53 enrolled
GastrointestinalHead & Neck

Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡